Eugene Major Email & Phone Number

Working on commercializing a patented Memorial Sloan Kettering Technology that uses natural language processing combined with deep domain expertise to analyze electronic health records/real world data/real world evidence to provide actionable insights to benefit various healthcare industry stakeholders.Participated in May-August 2024 NSF I-Corps Cohort run.

Invested in WavelyDx which builds phone-based tools to support pediatric care. Its first tool is a phone app that can detect fluid in the middle ear to help a doctor diagnose and treat ear infections remotely.

Invested in Ceretype Neuromedicine which provides actionable individual and population insights through unparalleled, commercializable visibility into brain circuitry—offering precision to stakeholders across the global healthcare ecosystem. This solution will bring new therapeutics to the market faster and revolutionize the treatment of psychiatric and.

Invested in Massive Bio, a leader in precision medicine and artificial intelligence enabled patient centric clinical trial enrollment. Massive Bio has a rapidly growing roster of clients across the pharmaceutical company and contract research organization industry globally.

Invested in NeuroRx, a biotechnology company founded by Princeton alumni. Company is developing a treatment for COVID-19-related Lung Injury and Acute Respiratory Failure (ARDS). Company has the first drug in development to treat bipolar depression in patients with acute suicidality. In May 2021, NeuroRx merged with a special purpose acquisition company.

Invested in GlossGenius, a software platform for beauty professionals co-founded by a Princeton alumna, in 2018. Met with hundreds of potential technology startup investments in Princeton alumni universe, Columbia Business School alumni network and Israeli entrepreneurial ecosystem.

Princeton Alumni Angels is a platform where Princeton University alumni work together to due diligence and invest in startups connected to Princeton alumni.

Invested in Goldilocks, a Memorial Sloan Kettering Cancer Center biotechnology spinout company founded by a Princeton alumnus and an MSKCC research scientist who is an alumnus of Robert Langer's bioengineering lab at M.I.T. Company is developing a treatment of kidney diseases utilizing proprietary mesoscale nanoparticle (MNP) versions of novel and already.

Evaluating potential investments in sectors impacted by current economic crisis including technology, healthcare, hospitality, fitness, real estate and energy among others. Made investment related to FED TALF 2020 program.

CH is a tech-enabled diabetes/chronic disease management company. Appointed by board to rebuild CH's finance function. Quickly stabilized situation so that CH could raise capital and regain confidence of key stakeholders. Put CH in position to focus on continued growth. Achievements included:-Quickly developed trust with CH team to analyze and get "buy-in".

Led effort to assess commercialization potential of synthetic protein design technology created by Princeton academics. Found a non-traditional non-dilutive partner/investor to advance development of insulin towards the goal of getting it in the hands of diabetics who have difficulty obtaining insulin at a reasonable price. Key achievements.

Introduced Wenspire to major potential U.S. customers - financial institutions and healthcare companies that have significant data that needs to be protected from cybersecurity threats. These potential customers included one of the largest global investment banks, one of the largest global commercial banks, and one of the largest healthcare insurance.

Introduced Segasec to major potential U.S. customers - financial institutions and healthcare companies that have significant data that needs to be protected from cybersecurity threats. These potential customers included one of the largest global investment banks, one of the largest Canadian banks, and a healthcare company.

Introduced Raycatch to potential U.S. customers - owners of large commercial solar assets. These potential customers included one of the largest global investment banks, one of the largest global private equity firms and one of the largest global hedge funds. Introduced Raycatch to a major U.S. owner of commercial solar assets that became Raycatch's first.

Columbia University spinout of drug delivery platform targeting diseases related to the brain.-First application hunts down glioblastoma (GBM) tumor cells and delivers anti-tumor drugs. -Technology comprises a mesenchymal stem cell (MSC) spheroid entrapping drug-loaded nanocomposite. The combination of MSC and nanoparticles enables this system to target.

RecurX Bio's phenotypic microfluidic assay captures the deadly cell sub-population responsible for cancer metastasis and rapid spread. The diagnostic test is used to determine how serious is the patient’s disease, reveal how well the standard of care treatment will work and uncover better existing drugs for personalized patient treatment. Johns Hopkins.

-Grew AUM from $1mm to $225mm with 100s of clients & multiple US/non-US investment entities.-Successfully navigated many market environments including 2008 crisis. Outperformed financial market and HF indices in 2008 and avoided leverage, frauds and other issues that hurt many funds.-Led monthly accounting/annual audit process for 20 years without any.

My first entrepreneurial start-up venture. Lido Partners was a long/short equity hedge fund which invested in equity, debt and other securities of public companies. Achievements included:-Managed an onshore fund, offshore fund and managed accounts.-Served as CFO - oversaw monthly accounting, annual audit and annual tax/K-1 process.-Led investment process.

Opportunity to serve as sole portfolio manager for the first time. Millennium Partners is a large multi-strategy hedge fund. Achievements included:-Managed a long/short portfolio which invested in equity, debt and other securities of public companies. -Led investment process and served as portfolio manager.-Conducted dozens of one-on-one due diligence.

Was hired away from Smith Barney. Odyssey Partners was one of the largest multi-strategy hedge funds at the time managed by famed investors Jack Nash and Leon Levy. Achievements included:-Assistant portfolio manager for portfolio of distressed securities (bank debt, subordinated debt, trade credit, preferred stock, common equity and other securities). -Was.

Associate in pre-eminent financial restructuring group hired by Smith Barney (now part of Citi) after Drexel Burnham Lambert went bankrupt. -Represented public companies undergoing complex financial restructurings.-Intensive due diligence of client prospects.-Construction of detailed models of future income statements, balance sheets and cash flow.

First job after completion of MBA. Associate in investment banking department at firm that pioneered the high yield bond market. -Financial restructuring transactions as described under Smith Barney above.-Also provided advice to public companies involved in initial public offerings of equity, high yield bond offerings, and mergers and.

Was hired away from Dean Witter Reynolds. Jamie Securities was one of the leading merger arbitrage firms at the time and one of the largest early hedge funds. Achievements included:-Analyzed private equity transactions and merger arbitrage investments.-Was analyst for portfolio comprised of several dozen companies undergoing complex merger/acquisition.

First job after college graduation. Dean Witter was one of the largest brokerage firms at the time (now part of Morgan Stanley). Achievements included:-Provided advice to public and private companies undergoing merger and/or leveraged buyout transactions.-Intensive due diligence of client prospects.-Construction of detailed models of future income.

New York, NY, US

Worked with Institutional Investor All-America specialty chemicals analyst, Charlie Rose, in equity research department while a student at Princeton.-Analyzed universe of public specialty chemicals companies for the purpose of investment recommendations to institutional investors.-Had to analyze the business, financial, legal and strategic aspects of the.

Bachelor Of Science And Engineering, Aerospace Engineering

Master Of Business Administration (Mba), Finance

Education record

Education record